Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1997
Implementation and evaluation of patient-specific three-dimensional internal dosimetry
K S Kolbert, G Sgouros, A M Scott, et al.
Cancer Research
|
April 5, 2000
A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D
A J Paige, K J Taylor, A Stewart, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 1, 1994
Clinical validation of SPECT and CT/MRI image registration in radiolabeled monoclonal antibody studies of colorectal carcinoma
A M Scott, H A Macapinlac, C R Divgi, et al.
Nuclear Medicine and Biology
|
July 1, 1994
Current status of radioimmunotherapy
S M Larson, C R Divgi, A Scott, et al.
The Science of the Total Environment
|
April 17, 2007
Indoor air quality in a dentistry clinic
C G Helmis, J Tzoutzas, H A Flocas, et al.
Nuclear Medicine and Biology
|
January 1, 1995
Calculated and TLD-based absorbed dose estimates for I-131-labeled 3F8 monoclonal antibody in a human neuroblastoma xenograft nude mouse model
O Ugur, A M Scott, L Kostakoglu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 7, 1998
Pharmacokinetic model of iodine-131-G250 antibody in renal cell carcinoma patients
A Loh, G Sgouros, J A O'Donoghue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 4, 2001
Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters
S V Govindan, D M Goldenberg, S E Elsamra, et al.
Blood
|
April 1, 1994
A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity
P C Caron, J G Jurcic, A M Scott, et al.
Cancer Research
|
March 31, 2001
Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591)
A M Ballangrud, W H Yang, D E Charlton, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1997
Implementation and evaluation of patient-specific three-dimensional internal dosimetry
K S Kolbert, G Sgouros, A M Scott, et al.
Cancer Research
|
April 5, 2000
A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D
A J Paige, K J Taylor, A Stewart, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 1, 1994
Clinical validation of SPECT and CT/MRI image registration in radiolabeled monoclonal antibody studies of colorectal carcinoma
A M Scott, H A Macapinlac, C R Divgi, et al.
Nuclear Medicine and Biology
|
July 1, 1994
Current status of radioimmunotherapy
S M Larson, C R Divgi, A Scott, et al.
The Science of the Total Environment
|
April 17, 2007
Indoor air quality in a dentistry clinic
C G Helmis, J Tzoutzas, H A Flocas, et al.
Nuclear Medicine and Biology
|
January 1, 1995
Calculated and TLD-based absorbed dose estimates for I-131-labeled 3F8 monoclonal antibody in a human neuroblastoma xenograft nude mouse model
O Ugur, A M Scott, L Kostakoglu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 7, 1998
Pharmacokinetic model of iodine-131-G250 antibody in renal cell carcinoma patients
A Loh, G Sgouros, J A O'Donoghue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 4, 2001
Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters
S V Govindan, D M Goldenberg, S E Elsamra, et al.
Blood
|
April 1, 1994
A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity
P C Caron, J G Jurcic, A M Scott, et al.
Cancer Research
|
March 31, 2001
Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591)
A M Ballangrud, W H Yang, D E Charlton, et al.
Page
of 7